Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis
about
Eggshell membrane: a possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studiesEggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled clinical studyEfficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trialsA 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo.Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiativeMetabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.Acute myocardial infarction following ingestion of a non-selective non-steroidal anti-inflammatory drug.Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.Cardiovascular risk of NSAIDs: time to translate knowledge into practiceAn evidence-based update on nonsteroidal anti-inflammatory drugs.Superior effect of forceful compared with standard traction mobilizations in hip disability?Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors.Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy.Regular use of traditional analgesics predicts major coronary events: A cohort study.Myths and facts in the use of anti-inflammatory drugs.Emerging drugs for treating skeletal muscle injury and promoting muscle repair.Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk.Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates.Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case-Control Study.Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study.Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study).An Observational 1-Month Trial on the Efficacy and Safety of Promerim for Improving Knee Joint.Deficits in pain treatment in nursing homes in Germany: a cross-sectional study.Cardiac safety of diclofenac at a single dose in ram.
P2860
Q24645101-FE83FC20-0DD1-406A-B136-2B6898467136Q24647966-D32F4DBA-DFCF-4859-A17D-C209B43ABB70Q31142712-D236E962-59F8-4116-86BD-7B3FF88FEB3AQ33367787-DFDB67B1-BF58-4C76-91D5-49DBBBCECD78Q33633625-BEC24236-3559-4B1A-8C92-35E1C5C1A56FQ34117657-31A6D86A-BE81-4161-A5B0-D77B5CFEBD29Q34165559-A018EDAA-9CCB-4BC6-98C6-96960FAD90DEQ34413209-A1D8D774-1B0B-4E05-8475-232E49D55F0FQ34536000-895C58EF-FB77-4749-A38E-0BF4BA8EF823Q34592490-9E951C56-376C-4E8F-91D1-9BE622A9AC65Q34592497-EFCC4860-0A3D-42A4-AA62-2D4181ACCD12Q35758411-E16E0029-24C3-4D5A-A067-ECCAAEBFE389Q36914849-F1EAE1AC-96AE-4473-8C17-1DE23903C2BAQ37061561-8958E951-F63E-4AFD-9AE1-FA70150A5540Q37173212-BB0E7673-49E3-45BF-93A8-5D52A2024577Q37230245-566BB5E3-3C91-4678-9D1E-F004BEDD9D6EQ37476911-33D12D53-902F-48EA-87A6-570FE78784D6Q37842502-A08F0283-FF9C-4A2F-861C-05997881DD8AQ38164425-59C53406-65D9-4ED4-BE67-6B340E6352C4Q38177340-C49E4041-18AF-41F1-AD02-A46A6BDB2B46Q38229056-5FE5F490-F7E5-4157-B58A-B81907DA8EB3Q38693695-6E076519-E26D-4655-A0FD-5805111EC5FCQ38732879-C508E606-9E40-43ED-B9A9-4ECA3401DD2EQ38941017-EFB47D72-27CB-4D73-900F-A66450F58FD6Q39160200-86C9F268-E549-43FE-B621-30306928B569Q41998132-19C113F1-E05E-46CC-BFC2-33803958EAA1Q52691461-99986432-EEED-4DE4-90B6-37822EA32398Q52889634-E95BAC74-83AF-412A-AFA7-D81BF4B8479BQ54397119-CB5AE42D-2A47-4FAC-B7BD-9571C0C5F90B
P2860
Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis
description
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
scientific article (publication date: 2006)
@en
vedecký článok (publikovaný 2006)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd in 2006)
@nl
наукова стаття, опублікована у 2006
@uk
مقالة علمية (نشرت عام 2006)
@ar
name
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@ast
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@en
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@nl
type
label
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@ast
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@en
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@nl
prefLabel
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@ast
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@en
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@nl
P2093
P2860
P921
P3181
P356
P1476
Risk of acute myocardial infar ...... mmatory drugs: a meta-analysis
@en
P2093
Gurkirpal Singh
Peter Langhorne
Rajan Madhok
P2860
P2888
P3181
P356
10.1186/AR2047
P407
P50
P577
2006-01-01T00:00:00Z
P5875
P6179
1025600432